Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qinzhuliangxue Keli for Subacute Eczema
NCT02517957Phase 2Unknown
- Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Aug 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Qinzhuliangxue Keli in Eczema, sponsored by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Status: unknown.
02
Drugs
Qinzhuliangxue Keli
03
Conditions
Eczema
Beyond the preview
Go deeper on NCT02517957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02517957.